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Summary
Genetic linkage, molecular analysis, and in situ hybridization have identified TYR and D11S388 as markers
flanking the chromosome 11 breakpoint in a large pedigree where a balanced translocation, t(1;11)(q43;q21),
segregates with schizophrenia and related affective disorders. Somatic cell hybrids, separating the two
translocation chromosomes from each other and from the normal homologues, have been produced with the aid
of immunomagnetic sorting for chromosome 1- and chromosome 11-encoded cell-surface antigens. The genes
for two of these antigens map on either side of the llq breakpoint. Immunomagnetic bead sorting was also used
to isolate two stable X-irradiation hybrids for each cell-surface antigen. Each hybrid carries only chromosome
11 fragments. Translocation and X-irradiation hybrids were analyzed, mainly by PCR, for the presence of 19
chromosome 11 and 4 chromosome 1 markers. Ten newly designed primers are reported. The X-irradiation
hybrids were also studied cytogenetically, for human DNA content, by in situ Cotd DNA hybridization and by
painting the Alu-PCR products from these four lines back onto normal human metaphases. The generation of
the translocation hybrids and of the chromosome 1lq fragment hybrids is a necessary preliminary to
determining whether a schizophrenia-predisposition gene SCZD2 is encoded at this site.
Introduction
A large Scottish pedigree (K26) has been described (St.
Clair et al. 1990) in which major mental illness, classifi-
able as schizoaffective disorder, was seen to segregate
with a balanced translocation, t(1;11)(q43;q21). The
family had been initially ascertained through a cytoge-
netic survey of mental hospitals and borstals (Jacobs et
al. 1970). Subsequently (St. Clair et al. 1990) it was
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found that 23 members of this family had psychiatric
diagnoses conforming to the details set out in Research
Diagnostic Criteria for mental and/or behavioral dis-
orders (Spitzer et al. 1987). Thirty-four of the 77 indi-
viduals karyotyped carried the translocation. Sixteen of
the 23 family members who had psychiatric diagnoses
had major mental illness; two others, not analyzed cyto-
genetically, had committed suicide. The five remaining
cases with psychiatric diagnoses but without the trans-
location did not have major mental illness (one had
generalized anxiety, one had minor depressive disorder,
and three were alcoholics). No physical dysmorphism
or mental handicap had been observed in this carefully
studied family.
Pedigrees with familial aggregations of common dis-
eases, with both genetic and environmental compo-
nents, are now used to unravel the specific genetic con-
tributions to such disease, in the hope of gaining insight
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into the biochemical pathways affected, thus allowing
us to think about therapy and prevention. A large pedi-
gree where the disease segregates tightly with a cytoge-
netic abnormality is an ideal starting point for identify-
ing the genetic component implicated at least in that
family. Obviously, a cosegregating translocation may
result in functional inactivation of a particular gene at
or near the breakpoint site, but we are aware that the
breakpoint may only be a closely linked marker for a
dominantly acting disease-predisposing allele that hap-
pens to be present in this family, at a nearby locus. Two
other, smaller families have been described with less
clear-cut cosegregation of mental illness with two inde-
pendent chromosome 11q translocations, one with
chromosome 9 and one with chromosome 6 (Smith et
al. 1989; Holland and Gosden 1990). The breakpoints
were not accurately defined. However, their existence
strengthened our interest in defining the exact site of
the translocation breakpoint in pedigree K26.
Cytogenetic banding analysis was carried out on pe-
ripheral blood chromosomes from selected individuals,
to confirm and refine the position of the breakpoint.
Lymphoblastoid cell lines were set up from key family
members, both translocation carriers and noncarriers.
Genetic linkage analysis was carried out with available
polymorphic markers in the region of the translocation,
by using markers both from chromosome 1 and from
chromosome 11. We expected to see suppression of
recombination in the vicinity of the translocation but
hoped to define more accurately the site of the break-
point. Using markers which showed little or no recom-
bination with the disease and the translocation in this
family, we used chromosomal in situ hybridization to
determine the position of the breakpoint, with the aid
of suitable large insert markers. However, with a view
to defining the breakpoint much more closely by posi-
tional cloning strategies, we also embarked on segregat-
ing the two translocation-derived chromosomes into
separate somatic cell hybrids, using cell-surface marker
selection strategies which we had developed for our
work on the short arm of chromosome 11 (Seawright et
al. 1988). The two independent pairs of mouse-human
hybrids so produced showed TYR to be above the
breakpoint and showed STMY1 to be below it. In situ
hybridization confirmed the tyrosinase assignment to
the derived chromosome 11 and showed the next most
closely linked distal 11q marker, D11S388 (cosmid
CJ52.4) (Julier et al. 1990), to be below the breakpoint.
The chromosome 1 breakpoint was also defined with
available markers and was found to be between D1S103
and D1S8. We then used DNA from the reciprocal
translocation hybrids MIS7 and MIS39 to set up and
refine PCR-based analyses for a number of chromo-
some 11q loci.
Cell-surface marker analysis revealed early on that
the two chromosome 11q markers MDU1 and MIC9
were, respectively, above and below the translocation
breakpoint. Therefore we set out to produce stable
chromosome-fragment hybrids, by X irradiation of the
chromosome 11-only hybrid J1CI4 Uones et al. 1984),
selecting for each marker separately. These were des-
tined to be both a mapping and a cloning resource, for
the production of new markers in regions defined by
earlier markers.
Material and Methods
Genetic Analysis of Selected Family Members
DNA was available for linkage analysis, from 10
translocation carriers and 5 noncarriers in the pedigree.
Individuals came from five branches of the family, each
separated by several meiotic events. Analysis was
carried out either by DNA blotting using informative
restriction digests or by PCR followed by sizing of dinu-
cleotide repeats on sequencing gels. Suitable markers
were chosen above and below the breakpoint positions
suggested by cytogenetic banding analysis on both
translocation chromosomes: on chromosome 11-
D11S97 (Jeffreys et al. 1988), TYR (Spritz et al. 1990;
Giebel et al. 1991), D11S388 (Julier et al. 1990), and
D11S35 (Litt et al. 1990); on chromosome 1-D1S81
(Nakamura et al. 1988), DlS103 (Weber et al. 1990),
and D1S8 (Royle et al. 1988). Of these, D11S35,
D1S103, and, latterly, TYR (Morris et al. 1991) were
analyzed as dinucleotide repeats.
Cell Culture and Fusion
Peripheral blood lymphocytes were isolated from a
number of cytogenetically normal and translocation-
carrying members of the pedigree. In most cases, perma-
nent B lymphoblastoid cell lines were produced by Ep-
stein-Barr virus (EBV) transformation (van Heyningen,
in press). Two cell lines, MAFLI and ROMAR, from
translocation individuals with major mental illness have
been used for most of the marker analyses. Culture of
peripheral lymphocytes and EBV cell lines was in RPMI
1640 medium with 10% FCS. Preexisting cell hybrids
were grown in appropriate medium: CF37, carrying an
X-1 1 translocation chromosome (Mohandas et al.
1980) was grown in HAT medium; CF52 has an 11-16
translocation chromosome as its sole human chromo-
some complement and was grown in medium selective
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for APRT (Koeffler et al. 1981). CF37 and CF52 were
the gift of Dr. T. Mohandas. The CMGT hybrids E67.1
and E67.4 have been described elsewhere (Porteous et
al. 1986) and have been analyzed in detail for short-arm
markers (Porteous et al. 1987). They were grown in
RPMI 1640 with 10% FCS.
The thioguanine-resistant, HPRT- mouse cell lines
used for fusion were Sp2/0-Ag4 (Shulman et al. 1978)
and RAG (Klebe et al. 1970). Polyethylene glycol
(PEG)-induced fusion, with MAFLI as the human par-
ent, was carried out according to a method described
elsewhere (van Heyningen, in press). The Sp2/0 hy-
brids, MIS series, grew in suspension and were sub-
cloned by limiting dilution. The attached cell hybrids,
MAR series, derived from RAG were subcloned by
seeding about 100 cells into small Falcon flasks and
transferring cell-surface marker-positive colonies into
2-ml wells 10-14 d after plating.
J1CI4 (a gift from Dr. Carol Jones; Jones et al. 1984)
is a hamster cell hybrid carrying an intact chromosome
11 as its only human component. WG3H is an HPRT-
hamster cell line used as the recipient in X-irradiation
fusions (Westerveld et al. 1971). Both of these cells
were routinely grown in RPMI 1640 with 10% FCS.
Cell-Surface Marker Selection and Analysis
Hybrid cell selection for the expression of cell-sur-
face markers expected on each "half" of the transloca-
tion chromosome was carried out under sterile condi-
tions by using magnetic beads. The monoclonal
antibodies used were in the form of sterile culture su-
pernatant produced in our laboratory from hybridoma
cells which we had bought or received as gifts. The
hybridomas to detect MIC10 (on chromosome 1),
MIC11, MIC4 (=CD44), MDU1, and MIC9 were, re-
spectively, TRA2.10 (Andrews et al. 1985), from Dr.
Peter Andrews; 163A5 (Woodroofe et al. 1984), from
Dr. Frank Walsh; F10.44.2 (Goodfellow et al. 1982),
from Dr. John Fabre; 4F2, from ATCC (HB-22); and
4D12 (Jones et al. 1984), from Dr. Peter Goodfellow.
Dynabeads M450 (sheep anti-mouse immunoglobu-
lin conjugated) were used. The stock suspension is 4
X 108 beads/ml (30 mg/ml). The most efficient separa-
tion is expected if all the available second antibody sites
are saturated with specific monoclonal antibody. One-
milligram (33 ,l = 1.3 X 107) aliquots of beads were
washed three times in sterile buffer (PBS and 1% BSA).
They were then incubated with end-over-end rotation
in 1 ml of each antibody in separate Eppendorf tubes
for 10 min. The antibody was discarded after the beads
were separated using the Dynabeads magnetic separa-
tor, and the coated beads were washed three times in
buffer, to remove any unbound antibody.
A very small number (1-2 beads/cell) of coated
beads were gently added to the cells suspended in PBS
and incubated at room temperature with rotation of
the samples, for 30 min. The beads, some with cells
attached, were then separated magnetically and were
washed three times in sterile serum-free medium and
finally were gently resuspended in culture medium and
were transferred to 2-ml wells.
For attached cells (the MAR hybrids) direct antigen-
positive clone selection of attached cells is possible in a
Falcon flask. The 30-min incubation of a 25-cm2 flask
with 104 coated beads/1 ml PBS is followed, without
washing but with gentle rocking of the flask, by inspec-
tion, under the microscope, for bead-binding clones
which can then be transferred into a 2-ml well by using
separate sterile bacterial loops for each.
Cells with beads attached are handled as little as pos-
sible, to prevent mechanical damage. They continue to
proliferate, and the beads are diluted out. Selection can
be repeated and may be alternated with subcloning and
quantitative fluorescence-activated cell sorter (FACS)
analysis.
FACS analysis was carried out according to a method
described elsewhere (Seawright et al. 1988; van Heynin-
gen, in press), except that the cell sorter used was a
Becton Dickinson FACSCAN. Anti-AFP monoclonal
antibody was used as a negative control. The propor-
tion of cell-surface marker-positive cells was estimated
from the machine-derived plot of cell number against
the log of fluorescence intensity.
Production of Cell-Surface Marker-selected
X-lrradiation Hybrids
The chromosome 11-only hybrid J1C14 (Jones et al.
1984) was used as the potential fragment donor, and
the HPRT- Chinese hamster cell line WG3H was used
as the rodent fusion partner. A total of 2 X 107 log-
phase J1C04 cells were harvested by gentle trypsiniza-
tion and were washed and resuspended in 2 ml of fresh
medium containing 10% FCS in a bijou bottle which
fits our gamma-irradiating cobalt source. A total of
16,000 rads were delivered to these cells. The cells were
then washed in serum-free medium and fused with 1.7
X 107 freshly harvested and washed WG3H cells, by
using our routine PEG fusion protocol. The fusion
products were plated into 8 X 75-cm2 flasks. HAT se-
lection was implemented 16 h later. Two weeks after
fusion, MDU1-positive and MIC9-positive clones were
sought in the flasks, initially by using Dynabeads coated
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with both antibodies. The positive colonies were
picked with bacterial loops, were grown up as clones in
25-cm2 flasks, and were reselected with the two anti-
bodies separately and sequentially. Clones were FACS
analyzed for all four chromosome 11-encoded cell-sur-
face markers, and samples were cryopreserved at every
stage. After repeated subcloning we obtained four rela-
tively stable independent hybrid clones, two carrying
each cell-surface marker in the absence of the others:
WJX3 and WJX7 are 100% MDU1 positive; and WJX5
and WJX11 are 100% MIC9 positive.
Mitotic Chromosome Preparation
The techniques used for both lymphoid cells and so-
matic cell hybrids were essentially as described else-
where (Fletcher, in press). For chromosome analysis by
in situ hybridization, cell synchronization with fluoro-
deoxyuridine is recommended. Mitotic cell prepara-
tions can be stored in methanol:acetic acid (3:1) for at
least 6 mo at -20'C. Spreads on slides were made as
required.
Chromosomal In Situ Hybridization
The markers used for this analysis were suggested by
preliminary linkage and hybrid cell results on determin-
ing flanking markers. Probes were labeled with biotin
by nick-translation using routine methods (described in
detail in Gosden 1990).
Slides were prepared 3-4 d before the hybridization
was carried out. The hybridization protocol was as de-
scribed by Gosden (1990).
Detection was essentially as described by Pinkel et al.
(1986), using (a) avidin-FITC (Vector Labs) as reporter
and (b) linking layers of FITC with biotinylated anti-
avidin. The slides were counterstained with propidium
iodide and were mounted in Citifluor antifade:glycerol.
They were examined on a Leitz Ortholux II microscope
equipped with Ploemopak fluorescence filters, and suit-
able metaphase spreads were scanned and stored with
the BioRad Lasersharp MRC 600 confocal laser scan-
ning system attached to the same microscope.
The markers used to define the breakpoint were a
lambda phage clone of tyrosinase and the next distal
marker, cosmid CJ52.4. The latter defines the locus
D11S388 (Julier et al. 1990).
Cytogenetic Analysis ofX Irradiation-Fragment Hybrids
The human DNA content of these hybrids was ana-
lyzed in several different ways. Mitotic chromosome
preparations from the subcloned stabilized hybrids
were hybridized with biotinylated human Cotl DNA
(GIBCO BRL), and signal was developed with a single
layer of avidin-FITC and was counterstained with pro-
pidium iodide in Citifluor by the method above. Hy-
bridization conditions used were as described by Gos-
den and Hanratty (1991b).
The origin of the human fragments in these hybrids
was also determined by chromosome painting. For this
the hybrid cell DNA was subjected to interrepeat se-
quence (IRS)-PCR using several primers for the human
Alu and Li interspersed repeated sequences (table 1;
Gosden and Hanratty 1991a; Dorin et al. 1992). The
PCR products were labeled with biotin by nick-transla-
tion and were used as a probe for in situ hybridization
back onto normal human mitotic spreads of relatively
extended chromosomes. Considerable suppression, by
adding 500 ng of unlabeled human Cotl DNA to 50 ng
labeled IRS-PCR product for each slide, was required
to give chromosome-specific results. Hybridization and
detection were essentially as described above for spe-
clfic marker in situ analysis.
Marker Analysis
DNA was prepared, by standard procedures de-
scribed elsewhere (van Heyningen, in press), from fro-
zen cell pellets, for all of the cell lines. Most marker
analysis was by PCR, and the products were analyzed
on agarose (1.5% for fragments of 500 bp). DNA blot
analysis was carried out for the chromosome 1 probes
D1S8 and D1S81.
Designing and Setting Up PCR Assays
for Chromosome II Markers
The aim was to set up PCR-based assays to quickly
analyze somatic cell hybrids for the presence of human
chromosome 11 markers on both mouse and hamster
backgrounds. Except for a few short-arm markers, we
concentrated on well-spaced long-arm markers. Where
no published primer sequences were available, we de-
signed our own, either from published gene sequences
or, in the case of D11S388, D11S385, and D11S351,
from data obtained by sequencing a fragment of the
insert from cloned probes. In order to try to keep the
PCR human-specific, primers were designed from un-
translated regions or introns, wherever such informa-
tion was available. Theoretical conditions were calcu-
lated for each primer pair and then were refined by
experimentation. Final primer sequences and annealing
temperatures are shown in table 1. For chromosome 1
markers-renin (REN) (Theune et al. 1991) and
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Table I
PCR Primers Used to Detect Genes in Somatic Cell Hybrids and for IRS-PCR for Painting Human DNA Content
of Hybrid Cells back to Normal Karyotype
Annealing Fragment
Temperature Size
Repeat Primer(s) (°C) (bp) Reference (remarks)
HBB ..........
D11S87.
TYRL ........
PGA ..........
MDU1 ........
FGF4 .........
GST3 .........
TYR ..........
D11S388.
STMY1.
CLG ..........
D11S385.
NCAM.
DRD2 .........
D1lS351.
THY1 .........
DlS1O3.
{5' ATG GTG CAC CTG ACT CCT GAG G 3'
5' GCC ATC ACT AAA GGC ACC GAG C 3'J
5' CCC TGG AAA CAC TTT CTG CC 3'
5' GGC TGG GTT GGA GGC AAG G 3'
{5' ACA ATA TGT TTC TTA GTC TG 3'1
5' TGG TAA CAC TAG ATT CAG C 3'
{5' GCA TCT CTG ACA CCA ATC AG 3'
5' TGG AGA AGA GAC AGA TGG AG 3'J
{5' TCT TCA AAG CCT CTG CAG TAC C 3'1
5' CTC ATC TCC AAC CTG TCT AAC C 3'
{5' GAT GAG TGC ACG TTC AAG GAG 3'1
5' CAG AGA TGC TCC ACG CCA TAC 3'
{5' GGG AGG GAT GAG AGT AGG ATG 3'1
5' GGA GGT TCA CGT ACT CAG GGG 3'
{5' GCA AGT TTG GCT TTT GGG GA 3'
5' CTG CCA AGA GGA GAA GAA TG 3'J
{5' CAT CCA CGC TGT TGG TCT GC 3'
5' CAG TAA GAA CCA AAG AAA GGT TAC 3'J
' CAG TTT TCT CCT CTA CCA AGA C 3'
5' ACT GGC TTT ACT TAG CTC TAT G 3'J
{5' AGT CAG TAC AGG AGC CGA ACA G 3'1
5' GGA GAA AAG CTG TGC ATA CTG G 3'J
(5' TTT TAT AGG GAC AGG ATC TTG C 3l
5' GGC TGT ATA ATC TTG TGT TCT C 3'J
{5' TGG AAA TCT CTT CCA AAC ATC GGA G 3'
5' AAT TAG AAC TTT GGA GAG GGA TGG G 3'J
{5' GAG GCC CTC TCA CTG ACA C 3'Y
5' AGT GCA GGG CCC TGC TGG A 3'J
(5' CTT GGG TAG CTG GTA CTA CAG G 3'
5' AGG TCA CTA CAC ATC AAA ACA GC 3'J
' CAG AAG GTG ACC AGC CTA ACG 3
5' CTG AGC ACT GTG ACG TTC TGG 3'J
{5' ACG AAC ATT CTA CAA GTT AC 3'
5' TTT CAG AGA AAC TGA CAT GT 3'J
65 355 In-house design
65
51
120 Lewis et al. 1988; in-house
sequence and design
260 Giebel et al. 1991 (exon 4
oligos P1 and P2; MspI
to distinguish from
TYR)
54 188 W. Cookson, personal
communication
57 859 Gottesdiener et al. 1988;
in-house design
(nt -1023 to -174)
62 542 Yoshida et al. 1987; in-
house design (nt 4161
to 4703)
60 450 Cowell et al. 1988; in-
house design (exons 5-7)
55 512 Giebel and Spritz 1990
(exon 1 oligos)
51 118
(variable)
50 300
Julier et al. 1990; in-house
sequence and design
Sirum and Brinkerhoff
1989; in-house design
(nt -300 to -4)
59 517 Angel et al. 1987; in-house
design (nt -434 to +83)
54
55
55
59
40
286 Julier et al. 1990; in-house
sequence and design
179 Barton et al. 1990
(nt -848 to -663;
designed by G. Gillett)
390 R. Todd, personal
communication (exon 2)
209 Julier et al. 1990;
in-house sequence and
design
324 Cotter et al. 1989 (with
slight modification)
55 >85
(variable)
Weber et al. 1990
(continued)
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Table I (continued)
Annealing Fragment
Temperature Size
Repeat Primer(s) (OC) (bp) Reference (remarks)
5' End Alu 5' AAAGTGCTGGGATTACAGG 3' 1
Consensus .... 5'GTGGCTCACGCCTGTAATCCC 3'J 60 Various Dorn et al. 1992
3' End Alul fS' GTGAGCCGAGATCGCGCCACTGCACT 3'1
ConsensusJ .... 'TGCACTCCAGCCTGGGCAACA 3 J 60
L1H ......... ' CATGGCACATGTATACATATAGTAAC(A/T)AACC 3' 60
HumanLiA ... 5' CACAGGAAGGGGAACATCACA 3' 60
HumanLiB .... 5' GGGGAGGGATAGCATTAGGAG 3' 60
DlS103 (Weber et al. 1990)-published PCR condi-
tions were used.
A problem which had to be overcome in the tyrosin-
ase analysis was the existence of the tyrosinase-like
gene (TYRLi), which was described in detail while the
present work was in progress (Giebel et al. 1991). This
allowed us to resolve TYRLi from TYR by using
primers to TYR exon 4, which is common to both loci;
but, after Mspl or HpaII digestion of the PCR product,
TYR gives rise to 120-bp and 140-bp fragments, while
the TYRLi products are 29 bp, 91 bp, and 149 bp (data
not shown). For the detection of TYR alone, primers
for exon 1 were used (table 1).
Results
Genetic Analysis
With the more distant but highly informative chro-
mosome 11 breakpoint-flanking markers D11S97 and
D11S35, two and three obligate recombinants, respec-
tively, were found among the 10 translocation carriers.
For the closer but less informative flanking markers
TYR and Dl 1S388, no recombinants were found, even
when DNA was reanalyzed for the recently described
TYR dinucleotide-repeat polymorphism (Morris et al.
1991). On chromosome 1 several recombinants are seen
with the highly informative distal marker D1S8, but
none was found with the proximal markers D1S103 or
DlS81-both of which are highly polymorphic refer-
ence markers. These results were emerging as the cell
hybrid analysis and the in situ hybridization were get-
ting under way and gave us an idea of the markers to
study, especially for the latter technique.
Marker Analysis of the Hybrid Cell Panel
The stabilized, repeatedly subcloned, cell-surface
marker-selected translocation hybrids were analyzed
mainly by PCR, once segregation of the two derived
chromosomes from their normal homologues had been
ascertained by cell-surface marker expression (fig. 1).
The X irradiation-fragment hybrids were screened in
the same way. Included in the panel for analysis, both
by PCR and for cell-surface markers, were potentially
useful preexisting translocation hybrids and earlier
CMGT fragment hybrids. High-molecular-weight
DNA was used for all analyses.
The PCR primers shown in table 1 were used to ana-
lyze the complete hybrid cell panel, including some ear-
lier CMGT chromosome-fragment hybrids. The com-
plete data set is shown in table 2, where the position of
the translocation breakpoint is clearly defined by hy-
brids MIS7 (=MAR12) and MIS39 (=MAR1), and the
marker analysis of the fragment hybrids gives an idea of
what chromosome 11 q regions are present for future
marker isolation.
Molecular Cytogenetic Analysis of the X Irradiation-
Fragment Hybrids
The human DNA content of the WJX hybrids was
analyzed by in situ hybridization using human Cotl
DNA. Figure 2 shows the distribution of the chromo-
some 11 fragments in each hybrid. In three of four cases
there appears to be a single block of human DNA, but
in WJX7 three separate blocks are seen, although all
three are located on the same recipient chromosome.
The appearance of the single extended region in WJX5
is nonuniform.
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Table 2
Marker Analysis of Translocation, X Irradiation, and CMGT Hybrids
STATUS OF CELL l INE(S)a
MIS7 MIS39 CF37
and and and
MAR12 MAR1 CF52 WJX3 WJX5 WJX7 WJX11 E67.1 E67.4
CHR 11 markers:
HBB ......... - + ND - + +
D11S87 ...... - + ND ND ND
MIC11 ....... - + - - + +
CD44 ........ - + - - - +
TYRL
.......
+ - + + - - +
PGA ......... - + - + - + + -
MDU1 ....... - + - + - + - -
FGF4
.........
- + + - -
GST3 ......... + - + - - + +
TYR ......... - + + - + + - +
D11S388 + - + - - - +
STMY1 ...... + + - + + + +
CLG ......... + - + + + + - +
D11S385 ..... + - + + + + +
NCAM
.......
+ - ND - - + + ND ND
DRD2
........
+ - ND - - + + ND ND
D11S351 ..... + - + + +
THY1 ........ + - + - + - + ND ND
MIC9 ........ ) - + + +
CHR 1 markers:
MIC10 ....... + - ND ND ND ND ND ND ND
REN ......... + - ND ND ND ND ND ND ND
DlS103 ...... + - ND ND ND ND ND ND ND
D1S8 ......... + ND ND ND ND ND ND ND
.pc s;i /1) U C r[cSIri U Iliar.i a;ndI cI U n /-\ U TiUL-) dUcIILI Ul mIrbii =NI)
Chromosome painting onto a normal human meta-
phase spread was also carried out to study directly the
chromosome 11 regions from which the human frag-
ments were derived. Figure 3 reveals an apparently sin-
gle contiguous region of chromosome 11q in WJX3,
WJX7, and WJX1 1. Three distinct regions, two on the
short arm and one on the long arm, are seen only in
WJX5, as expected on the basis of marker analysis (ta-
ble 2). Marker analysis would suggest the presence of
discontinuity in WJX7 too. Coti analysis of the hybrid
showed three separate blocks of human DNA in WJX7,
and the results in table 2 reveal two gaps-first, in the
HSTF1,GST3 region and, second, around D11S388.
This suggests that two small interstitial deletions have
interrupted contiguity, and the three separate blocks of
human DNA seen in the hybrid cell line may represent
the separate insertion of each contiguous segment.
However, as the gaps are small, the human DNA con-
tent of WJX7 appears as a single block when painted
back onto normal human chromosomes.
In Situ Hybridization to Determine the Site
of the Translocation Breakpoint
Figure 4 shows the results with the flanking markers
on mitotic chromosomes prepared from peripheral leu-
kocytes of translocation carrier and affected patient
ROMAR. Figure 4a shows the breakpoint-distal
marker Dl 1S388 hybridizing to the large derived chro-
mosome 1 and to the normal chromosome 11 homo-
logue, and figure 4b shows the TYR signal on the nor-
mal chromosome 11 and on the visibly smaller, derived
chromosome 11.
Discussion
Schizophrenia and related major mental illness are
very common in the general population (Gottesman
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Figure 2 Human DNA content of the WJX hybrids, revealed by in situ hybridization with Cotd fraction of human DNA. a, WJX3. b,
WJXS. c, WJX7. d, WJXI 1. For each cell line a representative mitotic spread is shown on the right, with an enlarged view of the human
fragment-bearing chromosome in the left panel.
and Shields 1982). The etiology of these diseases is not
understood but is almost certainly heterogeneous. So-
cial, environmental, and genetic components interact
to cause disease. Twin studies point to a major genetic
contribution (Gottesman and Shields 1982), which is,
however, likely to be due to several different interact-
ing genes. Any insight into the physiological/biochemi-
cal abnormalities which are involved in the onset of
disease may give a lead in designing improved therapy
and, perhaps, in devising preventive measures. Under-
standing the underlying pathology in one form of the
disease may lead to other candidate genes or to environ-
mentally alterable targets.
With this philosophy in mind, we set out to identify,
as a pointer to one candidate genetic component, the
translocation breakpoint which cosegregates closely
with schizophrenic illness in this large kindred. We
have succeeded in showing that the breakpoint lies be-
tween two adjacent genetically linked markers, TYR
and DlS388, initially placed 4 cM apart (C. Julier,
unpublished results) but most recently estimated to be
about 7.8 cM apart at 1ql4-q2l (NIH/CEPH Collab-
orative Mapping Group 1992). The DNA distance be-
tween two such markers is impossible to predict, since
the relationship between genetic and physical distance
is not constant, so that in part of the nearby 11q13
MEN1 region 1 cM corresponds to only 300 kb (Jan-
son et al. 1991). The next step is to identify the exact
site of the breakpoint, with the aid of further markers
in the TYR-D11S388 interval. With this in mind we
segregated the reciprocal translocation chromosomes
into stable mouse-human hybrids, for quick assignment
of any newly isolated markers. We have also produced
the four WJX series of X-irradiation hybrids carrying
1 lq fragments selected with cell-surface markers
known to map above and below the 1 q21 breakpoint.
Of these, WJX11 in particular reveals a contiguous
block of markers which appear to cross the transloca-
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Figure 3 Human DNA from each WJX hybrid, isolated by Alu-PCR and painted back onto normal human mitotic spreads. a, WJX3,
showing a subcentromeric block of DNA on llq. b, WJX5, revealing the presence of three distinct blocks, from 11pter, llpll-pl2, and
1 q23-q24 (the degree of Cotl suppression was not quite sufficient in this case, showing hybridization to some other chromosomes). c, WJX7,
showing a single relatively centromere-proximal block on llq. d, WJX11, with a more distal 1lq block of DNA. Each chromosome 11
homologue is shown enlarged separately in a small panel.
tion breakpoint. We cannot be certain of the integrity
of the DNA without PFGE analysis, since, for example,
in CMGT hybrids (of which E67.1 and E67.4 are repre-
sentative), we almost invariably find the human DNA
components to be rearranged when looked at by long-
range techniques (Bickmore et al. 1989). Alu-PCR
painting similarly reveals discontinuity in some chro-
mosome-fragment hybrids (Dorin et al. 1992). Never-
theless, such hybrids provide an excellent source of
new markers for the chromosome regions indicated to
be present by the preexisting markers (Porteous et al.
1987; Bickmore et al. 1989). However, to narrow
marker isolation more closely to the region of interest,
we propose to try coincidence sequence cloning
(Brookes and Porteous 1991)-for example, between
MIS39 (=MAR1) and WJX11, which carry overlapping
human fragments on a mouse cell background and
hamster cell background, respectively. Using this tech-
nique should allow us to isolate new markers solely for
the human region which the two cells have in common,
which is around the translocation breakpoint. Other
approaches in progress that are seeking to produce
markers for the region of interest include (a) the produc-
tion of microdissection libraries and (b) the isolation of
TYR and Dl1S388 yeast artificial chromosome (YAC)
clones, followed by YAC walking between these
clones. New markers produced are quickly mapped
onto the translocation hybrids MIS7, MIS39, and
CF37. Markers present in both MIS39 and CF37 or
WJXl 1 are automatically in the region of interest. Can-
didate YAC clones for crossing the breakpoint can be
identified by in situ hybridization (Breen et al. 1992)
onto the translocation cell line MAFLI.
In the process of producing and analyzing the so-
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Figure 4 In situ hybridization of the two adjacent flanking
markers on mitotic spreads from an affected translocation carrier. a,
Dl1S388, which hybridizes to the derived 1 (upper left) and to the
normal 11 homologue (lower left). b, TYR signals, seen on the normal
11 homologue (upper left) and on the truncated-looking derived 11
(lower left).
matic cell hybrids described, we have contributed to
the mapping effort on chromosome 11q. We have de-
vised human-specific PCR assays for a number of gene-
specific markers and have developed new sequence-
tagged sites for the D11S351, D11S385, and D11S388
(Julier et al. 1990) loci. The localization of the FACS-
selectable cell-surface marker MDU1 (Seawright et al.
1988), which is also the cloned gene 4F2 (Gottesdiener
et al. 1988), has been refined to the region proximal to
TYR but deleted in J1-44 on 11q (Jones et al. 1984;
Tanigami et al. 1992). It is interesting to note that,
although there is considerable fragmentation of the re-
tained chromosome fragments in WJX5 and WJX7,
markers known to be closely linked, such as the
CLG/STMY1 /D1 1S385 complex and NCAM/DRD2
(McConville et al. 1990), are not separated. These re-
sults suggest that such fragment hybrids will be useful
for short-range mapping.
Linkage studies of chromosome 11q markers with
schizophrenia have recently been carried out (Muir et
al. 1991). Interest in a possible disease association with
this chromosomal region has been influenced by (1) the
finding of three 1 1q21-q23 translocations (Smith et al.
1989; Holland and Gosden 1990; St. Clair et al. 1990),
(2) the existence of several published cases of schizo-
phrenia in albino patients, implicating the tyrosinase
region (Baron 1976; Clarke and Buckley 1989), and (3)
the presence of possible candidate loci, such as the do-
pamine D2 receptor (Grandy et al. 1989; Seeman et al.
1989). Although the results of these studies generally
have been negative, it is not possible to exclude the
involvement of a major locus SCZD2 in this region, in
as many as 20% of cases, making the isolation of genes
from the breakpoint region an important approach for
identifying specific schizophrenia-predisposition genes
which may be implicated in only a proportion of cases.
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